Cannara Biotech Inc Cash Flow Quality Index
Cannara Biotech Inc cash flow quality index. Cannara Biotech Inc (LOVE) has a Cash Flow Quality Index of 7.66x as of November 2025. Operating cash flow of CA$7.96 Million exceeds net income of CA$1.04 Million, indicating high earnings quality where cash backs reported profits. Explore Cannara Biotech Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Cannara Biotech Inc (2022–2025)
Cash flow quality index of Cannara Biotech Inc from 2022 to 2025. Historical Cash Flow Quality Index for Cannara Biotech Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. See Cannara Biotech Inc net asset quality index to measure how much of total assets are equity-financed.
Cannara Biotech Inc Cash Flow Quality Index by Year (2022–2025)
Cannara Biotech Inc cash flow quality index by year from 2022 to 2025. Year-by-year earnings quality comparison for Cannara Biotech Inc. For the full cash flow conversion analysis, see LOVE operating cash flow.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.53x | CA$20.01 Million | CA$13.08 Million | ▼ -7.8% |
| 2024 | 1.66x | CA$10.68 Million | CA$6.44 Million | ▲ +95.0% |
| 2023 | 0.85x | CA$5.91 Million | CA$6.95 Million | ▲ +132.3% |
| 2022 | -2.64x | CA$-6.08 Million | CA$2.31 Million | — |